HealthMerck Clears Clinical Trial Milestone, Shows Promise With Alzheimer’s Drug Verubecestat A new drug developed by Merck shows promise for the treatment of Alzheimer’s disease. Verubecestat, which is currently under clinical trial, is said to halt the beta amyloid plaque formation in brain.by Saranya Palanisamy
HealthNew High-Frequency Spinal Cord Stimulation Technique Found Effective Against Chronic Leg, Back Painby Livia Rusu
HealthNew Immunotherapy Technique Eliminates Up To 90 Percent Of Anaphylactic Response In Food Allergies With Just One Treatmentby Saranya Palanisamy
HealthResearchers Turn To Gene Editing System CRISPR To Facilitate Research On Curing HIVby Livia Rusu
HealthPrescription Testosterone, Other Steroid Drugs Product Labels Get New Warning From FDAby Carl Velasco
HealthDementia Risks Increase In Men Given Testosterone-Lowering Drugs To Treat Prostate Cancerby Saranya Palanisamy
HealthNew Wonder Drug? New Ibuprofen Formulation Touted As Safer, Offering Faster Pain Relief Than Current Versionby Dianne Depra
Master Google Assistant on Android: Top Google Assistant Tips, Powerful Voice Commands, and Must-Know AI Features